101 related articles for article (PubMed ID: 10970445)
1. Glutathione S-transferase mu1 (GSTM1) status and bladder cancer risk: a meta-analysis.
Johns LE; Houlston RS
Mutagenesis; 2000 Sep; 15(5):399-404. PubMed ID: 10970445
[TBL] [Abstract][Full Text] [Related]
2. Glutathione S-transferase M1 status and lung cancer risk: a meta-analysis.
Houlston RS
Cancer Epidemiol Biomarkers Prev; 1999 Aug; 8(8):675-82. PubMed ID: 10744127
[TBL] [Abstract][Full Text] [Related]
3. Glutathione S-transferase M1 status and gastric cancer risk: a meta-analysis.
La Torre G; Boccia S; Ricciardi G
Cancer Lett; 2005 Jan; 217(1):53-60. PubMed ID: 15596296
[TBL] [Abstract][Full Text] [Related]
4. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
5. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
6. Glutathione S-transferase M1 polymorphism and bladder cancer risk: a meta-analysis involving 33 studies.
Jiang Z; Li C; Wang X
Exp Biol Med (Maywood); 2011 Jun; 236(6):723-8. PubMed ID: 21558090
[TBL] [Abstract][Full Text] [Related]
7. Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control study.
Brockmöller J; Kerb R; Drakoulis N; Staffeldt B; Roots I
Cancer Res; 1994 Aug; 54(15):4103-11. PubMed ID: 8033143
[TBL] [Abstract][Full Text] [Related]
8. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
[TBL] [Abstract][Full Text] [Related]
9. Association of Glutathione S-transferase gene polymorphism with bladder Cancer susceptibility.
Zhou T; Li HY; Xie WJ; Zhong Z; Zhong H; Lin ZJ
BMC Cancer; 2018 Nov; 18(1):1088. PubMed ID: 30419877
[TBL] [Abstract][Full Text] [Related]
10. GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis.
Yu C; Hequn C; Longfei L; Long W; Zhi C; Feng Z; Jinbo C; Chao L; Xiongbing Z
Oncotarget; 2017 Jan; 8(2):3246-3258. PubMed ID: 27911277
[TBL] [Abstract][Full Text] [Related]
11. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review.
Engel LS; Taioli E; Pfeiffer R; Garcia-Closas M; Marcus PM; Lan Q; Boffetta P; Vineis P; Autrup H; Bell DA; Branch RA; Brockmöller J; Daly AK; Heckbert SR; Kalina I; Kang D; Katoh T; Lafuente A; Lin HJ; Romkes M; Taylor JA; Rothman N
Am J Epidemiol; 2002 Jul; 156(2):95-109. PubMed ID: 12117698
[TBL] [Abstract][Full Text] [Related]
12. Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer.
Salinas-Sánchez AS; Sánchez-Sánchez F; Donate-Moreno MJ; Rubio-del-Campo A; Gimenez-Bachs JM; Lorenzo-Romero JG; Serrano-Oviedo L; Escribano J
BJU Int; 2011 Jun; 107(11):1825-32. PubMed ID: 20942828
[TBL] [Abstract][Full Text] [Related]
13. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer.
Bell DA; Taylor JA; Paulson DF; Robertson CN; Mohler JL; Lucier GW
J Natl Cancer Inst; 1993 Jul; 85(14):1159-64. PubMed ID: 8320745
[TBL] [Abstract][Full Text] [Related]
14. A germline homozygote deletion of the glutathione-S-transferase Mu1 gene predisposes to bladder cancer.
Mungan NA; Aben KK; Beeks E; Kampman E; Bunschoten A; Bussemakers M; Witjes JA; Kiemeney LA
Urol Int; 2000; 64(3):134-8. PubMed ID: 10859543
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility genes: GSTM1 and GSTM3 as genetic risk factors in bladder cancer.
Schnakenberg E; Breuer R; Werdin R; Dreikorn K; Schloot W
Cytogenet Cell Genet; 2000; 91(1-4):234-8. PubMed ID: 11173863
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
[TBL] [Abstract][Full Text] [Related]
17. The role of human glutathione S-transferases M1 and T1 in individual susceptibility to bladder cancer.
Salagovic J; Kalina I; Habalová V; Hrivnák M; Valanský L; Biros E
Physiol Res; 1999; 48(6):465-71. PubMed ID: 10783912
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis.
Kim WJ; Lee HL; Lee SC; Kim YT; Kim H
J Urol; 2000 Jul; 164(1):209-13. PubMed ID: 10840461
[TBL] [Abstract][Full Text] [Related]
19. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
[TBL] [Abstract][Full Text] [Related]
20. Glutathione S-transferase T1 polymorphism contributes to bladder cancer risk: a meta-analysis involving 50 studies.
Gong M; Dong W; An R
DNA Cell Biol; 2012 Jul; 31(7):1187-97. PubMed ID: 22339266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
